Aandeel CENBF CEN BIOTECH, INC.
Toevoegen aan een lijst
Om deze functie te gebruiken moet u een klant of lid zijn.
InloggenRegistreren

Andere talen CEN Biotech, Inc.

Aandelen

CENBF

CA15130L1040

Beurs gesloten - OTC Markets
Andere beurzen
 17:49:14 29-04-2024 		Variatie 5 dagen Verschil t.o.v. 1 jan (%)
0,00738 USD +138,06% Intraday-grafiek van CEN Biotech, Inc. +138,71% +146,67%
2023 CEN Biotech, Inc. kondigt ontslag aan van Lawrence Lehoux als lid van de Raad van Bestuur en Chief Technology Officer CI
2022 CEN Biotech, Inc. meldt resultaten voor het derde kwartaal en de negen maanden eindigend op 30 september 2022 CI

Andere talen

Zoeken op
Resultaten bekijken
Krijg toegang tot al het nieuws over alle bedrijven: mis nooit meer een winstgevende beleggingskans!
Gratis inschrijven
CEN BIOTECH INC : Entry into a Material Definitive Agreement, Termination of a Material Definitive Agreement, Change in Directors or Principal Officers, Financial Statements and Exhibits (form 8-K)
CEN Biotech, Inc. Announces Resignation of Lawrence Lehoux as a Member of the Board and Chief Technology Officer
NOTE 2 - GOING CONCERN UNCERTAINTY / MANAGEMENT PLANS
CEN Biotech, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022
CEN BIOTECH INC : Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K)
CEN BIOTECH INC : Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K)
CEN BIOTECH INC : Entry into a Material Definitive Agreement, Unregistered Sale of Equity Securities, Change in Directors or Principal Officers, Financial Statements and Exhibits (form 8-K)
NOTE 2 - GOING CONCERN UNCERTAINTY / MANAGEMENT PLANS
CEN Biotech, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022
CEN BIOTECH INC : Entry into a Material Definitive Agreement, Termination of a Material Definitive Agreement, Financial Statements and Exhibits (form 8-K)
CEN BIOTECH INC : Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant, Unregistered Sale of Equity Securities, Financial Statements and Exhibits (form 8-K)
CEN BIOTECH INC : Entry into a Material Definitive Agreement, Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K)
CEN Biotech, Inc. announced that it has received $0.07 million in funding from 1800 Diagonal Lending, LLC
NOTE 2 - GOING CONCERN UNCERTAINTY / MANAGEMENT PLANS
CEN Biotech, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2022
CEN BIOTECH INC : Changes in Registrant's Certifying Accountant, Financial Statements and Exhibits (form 8-K)
CEN BIOTECH INC : Entry into a Material Definitive Agreement, Unregistered Sale of Equity Securities, Change in Directors or Principal Officers, Financial Statements and Exhibits (form 8-K)
CEN Biotech, Inc. Announces Changes to Its Board
CEN BIOTECH INC : Change in Directors or Principal Officers, Financial Statements and Exhibits (form 8-K)
CEN Biotech, Inc. Announces Management Changes
Geen resultaten voor deze zoekopdracht
Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Filters

Zoeken op

Datum van publicatie

Sinds de

Tot

  1. Beurs
  2. Aandelen
  3. Koers CENBF
  4. Nieuws CEN Biotech, Inc.
  5. Andere talen